The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work +617 570 1000
Fax +617 523 1231

John LeClaire

Work +1 617 570 1144


Partner Co-Chair, Private Equity


John LeClaire is co-founder and co-chair of the firm’s nationally ranked Private Equity Group, which was named the 2009 U.S. Buyout Firm of the Year by Buyouts magazine. The Goodwin Procter Private Equity Group serves leading private equity firms and growth companies operating in the U.S., Europe and Asia. Mr. LeClaire’s practice focuses on private equity transactions and relationships with growth companies. He joined Goodwin Procter in 1982 and has been a partner since 1989.


J.D., 1982 Boston University School of Law (magna cum laude) A.B., 1979 Brown University (magna cum laude)

United States: M&A/corporate and commercial

M&A: middle-market ($500m-999m)

Within: M&A: middle-market ($500m-999m)

Goodwin advises both buyers and sellers in transactions, including asset deals, stock deals, mergers, joint ventures and bankruptcy deals, and has longstanding experience in the technology, life sciences, business services, real estate, financial services and healthcare sectors. The firm also has a robust private equity practice. It advised EPR Properties on its acquisition of CNL Lifestyle Properties, together with co-buyer Och-Ziff Real Estate; and acted for biotechnology company Delinia in its sale to Celgene Corporation, which planned to expand its inflammation and immunology pipeline with Delinia’s preclinical-stage regulatory T cell therapy. Large deal matters included acting for biopharmaceutical services company PAREXEL International in its sale to Pamplona Capital Management; and assisting Albany Molecular Research with its sale to affiliates of The Carlyle Group and GTCR. Boston-based Mark Bettencourt advises private and public companies in the software, internet, digital media, robotics, communications, and networking equipment and information services industries; and Stuart Cable currently serves as chair of the M&A and corporate finance practices for the firm’s technology and life science business units. Other highly rated Boston practitioners include Joseph Johnson III, John Egan III, John Haggerty and John LeClaire. Silicon Valley-based Lawrence Chu, Joshua Klatzkin in Washington DC, Andrew Weidhaas, who divides his time between Los Angeles and New York, and Los Angeles-based Stephen Lee are also experienced practitioners.

[back to top]

Private equity buyouts

Within: Private equity buyouts

Goodwin continues to impress in growth equity, with clients recognizing the firm’s ability to span venture financing right through to leveraged buyouts, highlighting the ‘incredible service and responsiveness, cutting-edge legal advice, practical sensibilities and understanding of the need to get the deal done’. The firm is hailed as a ‘solution business’ and private equity clients note that portfolio companies often continue working with the team after private equity investors have exited. It is recognized for its particular strength in Boston and its leadership in real estate and healthcare deals, and recently it advised regular client Great Hill Partners on its respective acquisitions of PartsSource and Quantum Health. Boston-based John LeClaire and Michael Kendall and Los Angeles-based Andrew Weidhaas lead the practice. San Francisco’s Brian McPeake, New York partner Stuart Rosenthal and James Hutchinson in Washington DC are also recommended.

[back to top]

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to